<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">10877</article-id><article-id pub-id-type="doi">10.7554/eLife.10877</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>Aurkb/PP1-mediated resetting of Oct4 during the cell cycle determines the identity of embryonic stem cells</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-40095"><name><surname>Shin</surname><given-names>Jihoon</given-names></name><aff><institution content-type="dept">National Creative Research Center for Epigenome Reprogramming Network, Department of Biomedical Sciences, Ischemic/Hypoxic Disease Institute</institution>, <institution>Seoul National University College of Medicine</institution>, <addr-line><named-content content-type="city">Seoul</named-content></addr-line>, <country>Republic of Korea</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-40868"><name><surname>Kim</surname><given-names>Tae Wan</given-names></name><aff><institution content-type="dept">National Creative Research Center for Epigenome Reprogramming Network, Department of Biomedical Sciences, Ischemic/Hypoxic Disease Institute</institution>, <institution>Seoul National University College of Medicine</institution>, <addr-line><named-content content-type="city">Seoul</named-content></addr-line>, <country>Republic of Korea</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-40876"><name><surname>Kim</surname><given-names>Hyunsoo</given-names></name><aff><institution content-type="dept">National Creative Research Center for Epigenome Reprogramming Network, Department of Biomedical Sciences, Ischemic/Hypoxic Disease Institute</institution>, <institution>Seoul National University College of Medicine</institution>, <addr-line><named-content content-type="city">Seoul</named-content></addr-line>, <country>Republic of Korea</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-40884"><name><surname>Kim</surname><given-names>Hye Ji</given-names></name><aff><institution content-type="dept">Department of Biological Sciences</institution>, <institution>Seoul National University</institution>, <addr-line><named-content content-type="city">Seoul</named-content></addr-line>, <country>Republic of Korea</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-40870"><name><surname>Suh</surname><given-names>Min Young</given-names></name><aff><institution content-type="dept">Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science</institution>, <institution>Seoul National University</institution>, <addr-line><named-content content-type="city">Seoul</named-content></addr-line>, <country>Republic of Korea</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-40871"><name><surname>Lee</surname><given-names>Sangho</given-names></name><aff><institution content-type="dept">Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science</institution>, <institution>Seoul National University</institution>, <addr-line><named-content content-type="city">Seoul</named-content></addr-line>, <country>Republic of Korea</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-40872"><name><surname>Lee</surname><given-names>Han-Teo</given-names></name><aff><institution content-type="dept">Interdisciplinary Program in Genetic Engineering</institution>, <institution>Seoul National University</institution>, <addr-line><named-content content-type="city">Seoul</named-content></addr-line>, <country>Republic of Korea</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-49882"><name><surname>Kwak</surname><given-names>Sojung</given-names></name><aff><institution content-type="dept">National Creative Research Center for Epigenome Reprogramming Network, Department of Biomedical Sciences, Ischemic/Hypoxic Disease Institute</institution>, <institution>Seoul National University College of Medicine</institution>, <addr-line><named-content content-type="city">Seoul</named-content></addr-line>, <country>Republic of Korea</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-40885"><name><surname>Lee</surname><given-names>Sang-Eun</given-names></name><aff><institution content-type="dept">National Creative Research Center for Epigenome Reprogramming Network, Department of Biomedical Sciences, Ischemic/Hypoxic Disease Institute</institution>, <institution>Seoul National University College of Medicine</institution>, <addr-line><named-content content-type="city">Seoul</named-content></addr-line>, <country>Republic of Korea</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-40874"><name><surname>Lee</surname><given-names>Jong-Hyuk</given-names></name><aff><institution content-type="dept">National Creative Research Center for Epigenome Reprogramming Network, Department of Biomedical Sciences, Ischemic/Hypoxic Disease Institute</institution>, <institution>Seoul National University College of Medicine</institution>, <addr-line><named-content content-type="city">Seoul</named-content></addr-line>, <country>Republic of Korea</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-40875"><name><surname>Jang</surname><given-names>Hyonchol</given-names></name><aff><institution content-type="dept">Division of Cancer Biology, Research Institute</institution>, <institution>National Cancer Center</institution>, <addr-line><named-content content-type="city">Goyang</named-content></addr-line>, <country>Republic of Korea</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-23446"><name><surname>Cho</surname><given-names>Eun-Jung</given-names></name><aff><institution content-type="dept">College of Pharmacy</institution>, <institution>Sungkyunkwan University</institution>, <addr-line><named-content content-type="city">Suwon</named-content></addr-line>, <country>Republic of Korea</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-40189"><name><surname>Youn</surname><given-names>Hong-Duk</given-names></name><aff><institution content-type="dept">National Creative Research Center for Epigenome Reprogramming Network, Department of Biomedical Sciences, Ischemic/Hypoxic Disease Institute</institution>, <institution>Seoul National University College of Medicine</institution>, <addr-line><named-content content-type="city">Seoul</named-content></addr-line>, <country>Republic of Korea</country><email>hdyoun@snu.ac.kr</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-5530"><name><surname>Daley</surname><given-names>George Q</given-names></name><role>Reviewing editor</role><aff><institution>Harvard Medical School</institution>, <country>United States</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>15</day><month>02</month><year>2016</year></pub-date><elocation-id>e10877</elocation-id><history><date date-type="received"><day>14</day><month>08</month><year>2015</year></date><date date-type="accepted"><day>13</day><month>02</month><year>2016</year></date></history><permissions><copyright-statement>Â© 2016, Shin et al</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Shin et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>Pluripotency transcription programs by core transcription factors (CTFs) might be reset during M/G1 transition to maintain the pluripotency of embryonic stem cells (ESCs). However, little is known about how CTFs are governed during cell cycle progression. Here, we demonstrate that the regulation of Oct4 by Aurora kinase b (Aurkb)/protein phosphatase 1 (PP1) during the cell cycle is important for resetting Oct4 to pluripotency and cell cycle genes in determining the identity of ESCs. Aurkb phosphorylates Oct4(S229) during G2/M phase, leading to the dissociation of Oct4 from chromatin, whereas PP1 binds Oct4 and dephosphorylates Oct4(S229) during M/G1 transition, which resets Oct4-driven transcription for pluripotency and the cell cycle. Aurkb phosphor-mimetic and PP1 binding-deficient mutations in Oct4 alter the cell cycle, effect the loss of pluripotency in ESCs, and decrease the efficiency of somatic cell reprogramming. Our findings provide evidence that the cell cycle is linked directly to pluripotency programs in ESCs.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></back></article>